Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Economic considerations and formulary management of oral antipsychotics
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Economic considerations and formulary management of oral antipsychotics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clozapine
100%
Oral Antipsychotics
100%
Formulary Management
100%
Economic Considerations
100%
Risperidone
50%
Schizophrenia
37%
Antipsychotics
25%
Patients with Schizophrenia
25%
Typical Antipsychotics
25%
Agranulocytosis
25%
Novel Antipsychotics
25%
Adverse Effects
12%
Health Care Costs
12%
Clinical Efficacy
12%
Health Systems
12%
Olanzapine
12%
Atypical Antipsychotics
12%
Managed Care Organization
12%
U.S. Food
12%
Quetiapine
12%
Extrapyramidal Symptoms
12%
Healthcare Expenditure
12%
Second-generation Antipsychotics
12%
Novel Agents
12%
Healthcare Environment
12%
Indirect Costs
12%
Pharmacoeconomic Analysis
12%
Pharmacoeconomics
12%
Direct Costs
12%
Hospitalization Days
12%
Negative Symptoms
12%
Blood Count
12%
Restricted Use
12%
Treatment-resistant Patients
12%
Negative Symptoms of Schizophrenia
12%
Pharmacology, Toxicology and Pharmaceutical Science
Typical Antipsychotic
100%
Clozapine
100%
Risperidone
50%
Antipsychotic
25%
Agranulocytosis
25%
Negative Syndrome
25%
Pharmacoeconomics
25%
Adverse Event
12%
Olanzapine
12%
Extrapyramidal Symptoms
12%
Atypical Antipsychotics
12%
Quetiapine
12%
Retrospective Study
12%